Harpoon Therapeutics, Inc. Company Profile
News Articles
CMC Biologics signs development and manufacturing deal with Harpoon Therapeutics
CMC ICOS Biologics and Harpoon Therapeutics have signed an agreement to develop and manufacture HPN424, HPN536, and HPN217, representing three TriTAC molecules for the treatment of several human cance...
CMC Biologics to make Harpoon’s cancer drugs in Seattle, US
Harpoon Therapeutics has selected CMC Biologics to develop and manufacture three molecules for cancer treatments at the CDMOâs facilities in California and Washington State, US.
CMC Biologics to make Harpoon’s cancer drugs in California, US
Harpoon Therapeutics has selected CMC Biologics to develop and manufacture three molecules for cancer treatments at the CDMOâs facilities in California and Washington State, US.
Edwards Lifesciences buys Harpoon Medical for up to $250M
Edwards Lifesciences has purchased Baltimore-based Harpoon Medical for an initial $100 million, with
Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition
Harpoon's former CEO also hinted at possible growth at the office, including new hires for engineering and clinical team members.
CMC Bio, Harpoon Therapeutics Partner for Cancer Treatment
The manufacturing and development agreement involves three TriTAC molecules
CMC Biologics, Harpoon Therapeutics in Development & Mfg. Pact
CMC to employ CHEF1 Expression technology to facilitate production
Harpoon Finds Its Whale: Edwards Spends Up To $250m For Beating-Heart Mitral Repair Option
Edwards Lifesciences exercised a 2015 option to buy Harpoon, a spin-off from the University of Maryland's School of Medicine, for...
Drugs and Medications
Aldex [Pernix Therapeutics, LLC]
ALDEX GS™ Tablets
Aldex [Pernix Therapeutics, LLC]
ALDEX GS DMTablets
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
PubMed Articles
Transoesophageal echo-guided mitral valve repair using the Harpoon system.
Transapical off-pump echo-guided mitral valve repair with implantation of artificial ePTFE chordae with the Harpoon device has been proposed to treat patients presenting with severe mitral regurgitati...
Recent developments in intracellular protein delivery.
Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...
Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...
Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: Prospective Trial.
We evaluated safety and performance of the Harpoon Mitral Valve Repair System (H-MVRS), a transesophageal echocardiographic-guided device designed to implant artificial expanded polytetrafluoroethylen...
Clinical Trials
Impact of Ibis on Patients With Advanced COPD
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
Companies
Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, Ph.D., a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is f...
Maverick Therapeutics is pioneering the next generation of redirected T cell therapeutics in immuno-oncology. Maverickâs highly innovative platform is designed to deliver pot...
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
More Information about "Harpoon Therapeutics, Inc." on BioPortfolio
We have published hundreds of Harpoon Therapeutics, Inc. news stories on BioPortfolio along with dozens of Harpoon Therapeutics, Inc. Clinical Trials and PubMed Articles about Harpoon Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Harpoon Therapeutics, Inc. Companies in our database. You can also find out about relevant Harpoon Therapeutics, Inc. Drugs and Medications on this site too.
